← Back to Search

Hormone Therapy

Miacalcin Calcitonin Salmon Nasal Spray for Pelvic Fracture

Phase 4
Waitlist Available
Led By Brett Crist, MD
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the subject will be enrolled/assessed up to three months post-injury.
Awards & highlights

Study Summary

This trial is testing whether a medication can help reduce pain for elderly patients with pelvic fractures who are not undergoing surgery. The medication, intranasal salmon calcitonin, is given within the first 5 days after the injury.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the subject will be enrolled/assessed up to three months post-injury.
This trial's timeline: 3 weeks for screening, Varies for treatment, and the subject will be enrolled/assessed up to three months post-injury. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Calcitonin
Secondary outcome measures
Assess function and activity in geriatric patients with pelvic ring injuries using intranasal salmon calcitonin
Calcitonin
Calcitonin
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Miacalcin Calcitonin Salmon Nasal SprayExperimental Treatment1 Intervention
1 spray (200 IU) qDay, alternate nostrils daily
Group II: Non-Treatment GroupActive Control1 Intervention
This is the Non-Treatment Arm of the study. No intervention is to be administered.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Miacalcin Calcitonin Salmon Nasal Spray
2019
Completed Phase 4
~30

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
361 Previous Clinical Trials
627,973 Total Patients Enrolled
Brett Crist, MDPrincipal Investigator - University of Missouri-Columbia
Ellis Fischel Cancer Center of University of Missouri, University of Missouri Hospital
University Of Kansas School Of Medicine (Medical School)
University Ks School Of Medicine (Residency)
1 Previous Clinical Trials
35 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How have other research efforts examined the potential of Miacalcin Calcitonin Salmon Nasal Spray?

"At present, one clinical trial for Miacalcin Calcitonin Salmon Nasal Spray is running and it has not yet reached Phase 3. The primary location of this investigation is Columbia, Missouri but there are other sites conducting research as well."

Answered by AI

How many individuals are joining in this scientific experiment?

"Affirmative. Clinicaltrials.gov's records demonstrate that this experiment is actively enrolling participants, with 50 individuals required for the study which was first posted on July 1st 2019 and most recently updated on December 1st 2021 at one medical centre."

Answered by AI

Is this research project presently enlisting participants?

"Indeed, clinicaltrials.gov's records show that this medical trial is actively searching for patients to be recruited from one location. The study was initially posted on July 1st 2019 and underwent its latest update on December 1st 2021 with the aim of enrolling 50 participants."

Answered by AI

What is the typical application of Miacalcin Calcitonin Salmon Nasal Spray?

"Miacalcin Calcitonin Salmon Nasal Spray is used to fight osteoporosis, as well as hypercalcemia, accompanying fractures, and therapeutic procedures."

Answered by AI

Is the administration of Miacalcin Calcitonin Salmon Nasal Spray associated with any adverse effects?

"The safety of Miacalcin Calcitonin Salmon Nasal Spray has been ascertained in Phase 4 trials and therefore merits a score of 3."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries
Brett Crist 2019. "The Use of Intranasal Calcitonin to Improve Pain and Activity in Elderly Pelvic Ring Injuries". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03812991.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top